Lysine-specific demethylase 1 as a potential therapeutic target
about
Design of small molecule epigenetic modulatorsMolecular basis for the autoregulation of the protein acetyl transferase Rtt109LSD2/KDM1B and Its Cofactor NPAC/GLYR1 Endow a Structural and Molecular Model for Regulation of H3K4 DemethylationKDM1 class flavin-dependent protein lysine demethylasesFolate deficiency facilitates recruitment of upstream binding factor to hot spots of DNA double-strand breaks of rRNA genes and promotes its transcriptionComputational methods for de novo protein design and its applications to the human immunodeficiency virus 1, purine nucleoside phosphorylase, ubiquitin specific protease 7, and histone demethylases.Post-translational modifications of nucleosomal histones in oligodendrocyte lineage cells in development and disease.Novel histone demethylase LSD1 inhibitors selectively target cancer cells with pluripotent stem cell properties.Mild Glucose Starvation Induces KDM2A-Mediated H3K36me2 Demethylation through AMPK To Reduce rRNA Transcription and Cell ProliferationEvaluating epigenetic landmarks in the brain of multiple sclerosis patients: a contribution to the current debate on disease pathogenesisRecent advances in the development of polyamine analogues as antitumor agents.Polyamine analogues targeting epigenetic gene regulation.Inhibitors of emerging epigenetic targets for cancer therapy: a patent review (2010-2014).(Bis)urea and (bis)thiourea inhibitors of lysine-specific demethylase 1 as epigenetic modulators.JmjC enzyme KDM2A is a regulator of rRNA transcription in response to starvation.Synthesis and evaluation of novel cyclic Peptide inhibitors of lysine-specific demethylase 1.Cyclopropanamine Compounds and Use ThereofPolyamine-based small molecule epigenetic modulators.Low molecular weight amidoximes that act as potent inhibitors of lysine-specific demethylase 13,5-Diamino-1,2,4-triazoles as a novel scaffold for potent, reversible LSD1 (KDM1A) inhibitors.New histone demethylase LSD1 inhibitor selectively targets teratocarcinoma and embryonic carcinoma cells.
P2860
Q26850027-92E73A40-66B8-425F-8027-3CE46E7FF136Q27651742-C2E29707-2694-490A-B3D0-DE9CF06EA15CQ27675574-1B808D9D-5F4B-49FD-9C64-5502D4185B14Q28084876-7D099A8E-1BD5-4CCC-B276-C73E52AA9D39Q33558438-06E170DE-8759-419C-B66C-3EAB125CCE65Q33951142-2844E429-C690-4E73-8C65-F883686D84A9Q34584859-34B306CE-548D-4D8C-93B8-BFFD5129A3E6Q35587244-9E06C393-3CB7-4364-9CDC-6F00BE9AFAA5Q36289555-7DC14425-904E-48A1-B1F8-7233C8341058Q37130888-8B6F7BF1-A0E5-4BCE-9B1C-138B23450749Q37522449-C071E018-75DB-4107-83A1-002D7727EC7FQ37679985-62925BE6-B366-4F28-A8CA-8C8DB35D1D3AQ38547122-7A125232-8206-438D-BE98-1AB8F1E9BAD5Q39689810-501DB825-D246-49DB-B78F-193D08379DABQ39716956-C96D1DA3-4A0A-4447-AB41-23961A3DF0D2Q39786614-61D48A7D-38AC-481D-A7A3-0C9597DBD59CQ41815773-ABD0D4C0-8248-4FA8-A0F7-4806F11F3245Q41911402-BCF644FD-06A0-43DC-BEA5-22614128CDC9Q42399366-2FD79F1A-4EF5-4744-8DDB-D75349BEF3ABQ43094404-F128B418-F376-434B-AE3E-1A9359FE637BQ50028731-E310339C-91C1-406B-896A-75DAE9B8A961
P2860
Lysine-specific demethylase 1 as a potential therapeutic target
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Lysine-specific demethylase 1 as a potential therapeutic target
@ast
Lysine-specific demethylase 1 as a potential therapeutic target
@en
Lysine-specific demethylase 1 as a potential therapeutic target
@nl
type
label
Lysine-specific demethylase 1 as a potential therapeutic target
@ast
Lysine-specific demethylase 1 as a potential therapeutic target
@en
Lysine-specific demethylase 1 as a potential therapeutic target
@nl
prefLabel
Lysine-specific demethylase 1 as a potential therapeutic target
@ast
Lysine-specific demethylase 1 as a potential therapeutic target
@en
Lysine-specific demethylase 1 as a potential therapeutic target
@nl
P2860
P1476
Lysine-specific demethylase 1 as a potential therapeutic target
@en
P2093
André Hoelz
Pete Stavropoulos
P2860
P304
P356
10.1517/14728222.11.6.809
P407
P577
2007-06-01T00:00:00Z